Kingdon Capital Management, L.L.C. Foghorn Therapeutics Inc. Transaction History

Kingdon Capital Management, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$8.48 - $16.84 $459,963 - $913,418	-54,241 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$8.87 - $22.1 $886 - $2,210	-100 Reduced 0.18%	54,241 $826,000
Q4 2021 Feb 14, 2022	SELL	$10.79 - $22.87 $1.63 Million - $3.46 Million	-151,400 Reduced 73.59%	54,341 $1.24 Million
Q3 2021 Nov 15, 2021	BUY	$8.33 - $15.02 $1.71 Million - $3.09 Million	205,741 New	205,741 $2.87 Million

33.3M

8.7K

2.4K

Ticker FHTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,637,400
Market Cap $313M
Description
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.